Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07716475

Evaluate the Effectiveness and Safety of At-Home Rehabilitation Gait Training Using a Hip-assisted Wearable Robot in Stroke Patients

The goal of this clinical trial is to learn whether a wearable monitoring system can help adults who have had a stroke get more out of a home exercise program. The system tracks how participants walk and move, then gives them feedback. Researchers want to know if this feedback improves walking, thinking and memory, and daily activity.

The wearable monitoring system has three parts:

A shoe insole sensor that measures how a person walks A wrist band that tracks daily activity, like a fitness watch A mobile app that gives feedback and lets participants report how they feel

The main questions this study aims to answer are:

Does feedback from the wearable system improve physical function, thinking and memory, and daily activity during a home exercise program? How satisfied are participants with using the wearable system?

Researchers will compare two groups. Both groups do the same home exercise program for 6 weeks. One group uses the wearable system and gets feedback. The other group does the program without the wearable system or feedback. This comparison shows whether the feedback itself makes a difference.

Who can take part: adults who have had a stroke and [key eligibility in plain words, e.g., "can walk a short distance with or without help"]. The study plans to enroll about [number] participants.

Participants in the wearable group will:

Get an insole sensor, a wrist activity tracker, and access to a mobile app Learn a home exercise program from the study team Wear the insole sensor and activity tracker while exercising at home for 6 weeks Use the app to see their feedback and report daily health information Complete a survey about their experience at the end

Participants in the comparison group will:

Do the same home exercise program for 6 weeks, without the wearable system or feedback.

Recruiting

Interested in participating?

Request Info

Key information

Age range

19 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

After obtaining written consent, a screening test is performed. In the screening test, after taking a history of the subject's baseline symptoms and signs, the past history and medication history are confirmed, vital signs are measured, and a physical examination is conducted, and the overall gait status such as whether assistive devices are used during gait and the gait pattern is assessed. Subjects who pass the screening test undergo the initial assessment within 7 days.

The initial assessment is conducted including the 2-Minute Walk Test, spatiotemporal gait parameters, the Berg Balance Scale, and subjects who complete the initial assessment begin robot-assisted gait training on the same day.

After the initial assessment, gait training using the hip-assisted wearable robot is performed in the home or an indoor space near the home twice a week for 2 weeks, a total of 4 times, for 30 minutes each. The interval between each intervention visit is set not to exceed 5 days.

After the end of the 2 weeks of robot-assisted gait training, on the day of completion, the end-of-study assessment is performed identically to the initial assessment, and a satisfaction assessment for the hip-assisted wearable robot is conducted.

In addition, when a device abnormality occurs, measures are taken and the relevant details are recorded, the usability of the hip-assisted wearable robot is analyzed, the gait and balance function assessment results in the non-wearing/wearing states of the hip-assisted wearable robot are statistically compared before and after gait training, and the burden and satisfaction assessments of the hip-assisted wearable robot are analyzed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 19 years or older and under 80 years
  • Persons diagnosed with cerebral infarction or intracerebral hemorrhage confirmed by magnetic resonance imaging or computed tomography
  • Persons for whom at least 1 month has elapsed since the diagnosis of stroke
  • Persons showing a spastic hemiplegic gait pattern due to stroke
  • Patients with a Functional Ambulatory Category score below 4
  • Persons who can sit without assistance at the edge of a bed and can stand for 10 seconds with or without assistance
  • Persons with sufficient cognitive ability to follow simple instructions and understand the content and purpose of the study (Mini-Mental State Examination score >= 20)

Exclusion criteria

  • Persons with contraindications to lower-extremity weight bearing, such as severe lower-extremity joint contracture or an untreated fracture
  • Persons for whom wearing the device is difficult due to skin disease or open wounds
  • Persons with a severe difference in the length of the two lower extremities
  • Persons with severe deformity or joint contracture in the lower extremities
  • Persons unable to maintain a sitting posture or a standing posture on their own
  • Persons with severe lower-extremity spasticity (Modified Ashworth Scale (MAS) grade 2 or higher)
  • Persons who cannot cooperate with gait therapy using the robot-assisted orthopedic exercise device due to severe cognitive decline (Mini-Mental State Examination score < 20), delirium, or severe language function impairment
  • Persons who cannot maintain prolonged standing or walking due to underlying conditions such as orthostatic hypotension or reduced cardiopulmonary function
  • Persons with other concomitant conditions affecting gait, such as peripheral neuropathy or parkinsonism due to alcoholism or severe diabetes
  • Pregnant women or patients with the possibility of pregnancy
  • Persons currently participating in another clinical trial
  • Persons at high risk in the event of a fall or bleeding due to a coagulation disorder or the like
  • Persons with a height less than 140 cm or greater than 190 cm
  • Persons for whom wearing the robot is not possible
  • Persons with clinically significant findings that, in the medical judgment of the principal investigator or a sub-investigator, are considered inappropriate for this study other than the above

Treatment and study plan

hip-assisted wearable robot

Device

A hip-assisted wearable robot (wearable gait-assist robot) that assists flexion and extension of the hip joint during walking. The battery-powered device is controlled through a paired mobile application via Bluetooth, and its assistive force can be adjusted to each participant. A visiting physical or occupational therapist applies the device and delivers gait training at the participant's home for 4 sessions over 2 weeks, 30 minutes per session, under a physician's prescription and supervision.

Primary outcomes

  1. Telehealth Usability Questionnaire (TUQ)

    Time frame: At the end of the 2-week intervention (after session 4)

    Usability of the home-based robot-assisted gait rehabilitation service, measured with a questionnaire based on the Telehealth Usability Questionnaire (TUQ). Items are rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree); higher scores indicate better usability. Total and item scores are summarized.

Secondary outcomes

  1. Distance of 2-Minute Walk Test (2MWT)

    Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)

    Patients are instructed to walk back as many times as possible within 2 minutes. The examiner records the total distance covered, abnormal gait patterns, and the time of occurrence of any gait deviations.

  2. Spatiotemporal Parameters of Gait: Cadence

    Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)

    While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Cadence: The number of steps taken per minute, measured in steps per minute (spm).

  3. Spatiotemporal Parameters of Gait : Total Step Count

    Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)

    While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Total Step Count: The total number of steps taken during walking.

  4. Spatiotemporal Parameters of Gait : Self-Selected Walking Speed

    Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)

    While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Self-Selected Walking Speed: The participant's walking speed when walking naturally at a comfortable pace.

  5. Spatiotemporal Parameters of Gait : Distance

    Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)

    While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Distance: The total distance covered during walking, measured in meters (m).

  6. Spatiotemporal Parameters of Gait : Stride Length

    Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)

    While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Stride Length: The distance between the heel of one foot to the heel of the same foot during consecutive steps. Measured in meters (m), stride length is adjusted for height to account for differences in body size.

  7. Berg Balance Scale (BBS)

    Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)

    Patients are asked to perform 14 tasks regarding the static and dynamic balance of patients. Each task was rated on a five-point scale from 0 to 4, with a total score of 56.

  8. Participant Satisfaction (K-QUEST 2.0-based)

    Time frame: At the end of the 2-week intervention (after session 4)

    Satisfaction with the device and home-based service, measured with the 12-item, 5-point Korean version of the Quebec User Evaluation of Satisfaction with Assistive Technology (K-QUEST 2.0). Each item is scored from 1 to 5, and the total score is the sum of the 12 items, ranging from a minimum of 12 to a maximum of 60. Higher scores indicate greater satisfaction.

Study contacts

Contact information is provided by the study sponsor or research team.

Na Young Kim, MD, PhD

CONTACT

[email protected]

+82 010 9127 4482

Seung Ick Choi

CONTACT

[email protected]

+82 010 8821 5297

Sponsors and collaborators

Lead sponsor

Yonsei University

Other

Collaborators

  • Korea Health Industry Development Institute

Registry information

Official study title

A Study to Evaluate the Effectiveness and Safety of At-Home Rehabilitation Gait Training Using a Hip-assisted Wearable Robot in Stroke Patients: An Investigator-Initiated, Single-Center, Single-Arm Exploratory Trial

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Jul 21, 2026
Registry last updated
Jul 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.